Yang S - Search Results

1

Silencing PPA1 inhibits human epithelial ovarian cancer metastasis by suppressing the Wnt/β-catenin signaling pathway.

Niu H, Zhou W, Xu Y, Yin Z, Shen W, Ye Z, Liu Y, Chen Y, Yang S, Xiang R, Wang L, Qu P. Niu H, et al. Among authors: yang s. Oncotarget. 2017 Jul 18;8(44):76266-76278. doi: 10.18632/oncotarget.19346. eCollection 2017 Sep 29. Oncotarget. 2017. PMID: 29100310 Free PMC article.

2

BMP-6 inhibits cell proliferation by targeting microRNA-192 in breast cancer.

Hu F, Meng X, Tong Q, Liang L, Xiang R, Zhu T, Yang S. Hu F, et al. Among authors: yang s. Biochim Biophys Acta. 2013 Dec;1832(12):2379-90. doi: 10.1016/j.bbadis.2013.08.011. Epub 2013 Sep 6. Biochim Biophys Acta. 2013. PMID: 24012720 Free article.

3

Ifit1 Protects Against Lipopolysaccharide and D-galactosamine-Induced Fatal Hepatitis by Inhibiting Activation of the JNK Pathway.

Chang A, Chen Y, Shen W, Gao R, Zhou W, Yang S, Liu Y, Luo Y, Chuang TH, Sun P, Liu C, Xiang R. Chang A, et al. Among authors: yang s. J Infect Dis. 2015 Nov 1;212(9):1509-20. doi: 10.1093/infdis/jiv221. J Infect Dis. 2015. PMID: 26459629 Free PMC article.

4

The novel VEGF receptor 2 inhibitor YLL545 inhibits angiogenesis and growth in breast cancer.

Zhang J, Liu C, Shi W, Yang L, Zhang Q, Cui J, Fang Y, Li Y, Ren G, Yang S, Xiang R. Zhang J, et al. Among authors: yang s, yang l. Oncotarget. 2016 Jul 5;7(27):41067-41080. doi: 10.18632/oncotarget.9392. Oncotarget. 2016. PMID: 27203384 Free PMC article.

5

Clinical significance and functional validation of PPA1 in various tumors.

Luo D, Wang G, Shen W, Zhao S, Zhou W, Wan L, Yuan L, Yang S, Xiang R. Luo D, et al. Among authors: yang s. Cancer Med. 2016 Oct;5(10):2800-2812. doi: 10.1002/cam4.894. Epub 2016 Sep 26. Cancer Med. 2016. PMID: 27666431 Free PMC article.

6

LMO2 promotes tumor cell invasion and metastasis in basal-type breast cancer by altering actin cytoskeleton remodeling.

Liu Y, Wang Z, Huang D, Wu C, Li H, Zhang X, Meng B, Li Z, Zhu T, Yang S, Sun W. Liu Y, et al. Among authors: yang s. Oncotarget. 2017 Feb 7;8(6):9513-9524. doi: 10.18632/oncotarget.13434. Oncotarget. 2017. PMID: 27880729 Free PMC article.

7

ZEB1 induces ER-α promoter hypermethylation and confers antiestrogen resistance in breast cancer.

Zhang J, Zhou C, Jiang H, Liang L, Shi W, Zhang Q, Sun P, Xiang R, Wang Y, Yang S. Zhang J, et al. Among authors: yang s. Cell Death Dis. 2017 Apr 6;8(4):e2732. doi: 10.1038/cddis.2017.154. Cell Death Dis. 2017. PMID: 28383555 Free PMC article.

8

ZEB1 confers stem cell-like properties in breast cancer by targeting neurogenin-3.

Zhou C, Jiang H, Zhang Z, Zhang G, Wang H, Zhang Q, Sun P, Xiang R, Yang S. Zhou C, et al. Among authors: yang s. Oncotarget. 2017 Apr 13;8(33):54388-54401. doi: 10.18632/oncotarget.17077. eCollection 2017 Aug 15. Oncotarget. 2017. PMID: 28903350 Free PMC article.

9

ZEB1 confers chemotherapeutic resistance to breast cancer by activating ATM.

Zhang X, Zhang Z, Zhang Q, Zhang Q, Sun P, Xiang R, Ren G, Yang S. Zhang X, et al. Among authors: yang s. Cell Death Dis. 2018 Jan 19;9(2):57. doi: 10.1038/s41419-017-0087-3. Cell Death Dis. 2018. PMID: 29352223 Free PMC article.

10

Epigenetic dysregulation of ZEB1 is involved in LMO2-promoted T-cell acute lymphoblastic leukaemia leukaemogenesis.

Wu C, Li J, Tian C, Shi W, Jiang H, Zhang Z, Wang H, Zhang Q, Sun W, Sun P, Xiang R, Yang S. Wu C, et al. Among authors: yang s. Biochim Biophys Acta Mol Basis Dis. 2018 Aug;1864(8):2511-2525. doi: 10.1016/j.bbadis.2018.05.013. Epub 2018 May 17. Biochim Biophys Acta Mol Basis Dis. 2018. PMID: 29778661 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

54,133 results

Search Page

Filters